Prostate cancer: open trials in Japan

43 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Akita University Hospital ( Site 0904), Akita · Asahikawa Medical University Hospital ( Site 0901), Asahikawa · Kyushu University Hospital ( Site 0919), Fukuoka · Fukushima Medical University Hospital ( Site 0933), Fukushima · Gifu University Hospital ( Site 0910), Gifu · Kansai Medical University Hospital ( Site 0912), Hirakata · Hiroshima University Hospital ( Site 0916), Hiroshima · Kagoshima University Hospital ( Site 0929), Kagoshima · Nara Medical University Hospital ( Site 0915), Kashihara · Kagawa University Hospital ( Site 0917), Kita · Hospital of the University of Occupational and Environmental Health, Japan ( Site 0921), Kitakyushu · Kobe University Hospital ( Site 0914), Kobe · National Hospital Organization Kumamoto Medical Center ( Site 0924), Kumamoto · Kurume University Hospital ( Site 0920), Kurume · The Jikei University Hospital ( Site 0907), Minato · University of Miyazaki Hospital ( Site 0926), Miyazaki · Miyazaki Prefectural Miyazaki Hospital ( Site 0927), Miyazaki · Kanazawa Medical University Hospital ( Site 0909), Mukai-awagasaki · Nagano Municipal Hospital ( Site 0932), Nagano · National Hospital Organization Oita Medical Center ( Site 0925), Ōita · National Hospital Organization Nagasaki Medical Center ( Site 0923), Ōmura · Saga-Ken Medical Centre Koseikan ( Site 0922), Saga · Bell Land General Hospital ( Site 0913), Sakai · Toho University Sakura Medical Center ( Site 0906), Sakura · Sapporo Medical University Hospital ( Site 0902), Sapporo · Hokkaido University Hospital ( Site 0931), Sapporo · Nanbu Tokushukai Hospital ( Site 0930), Shimajiri · The University of Osaka Hospital ( Site 0911), Suita · Ehime University Hospital ( Site 0918), Tōon · Yokohama City University Medical Center ( Site 0908), Yokohama
Registry updated 2026-11-05
NCT06661122
A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer
Research · Bayer
Many Locations, Many Locations
Registry updated 2026-11-05
NCT06122584
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
Trial Treatment · Phase 3 · ABX advanced biochemical compounds GmbH
The University of Osaka Hospital, Osaka · National Cancer Center, Tokyo · Jikei University Hospital, Tokyo
Registry updated 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
National Cancer Center Hospital, Chūōku · National Cancer Center Hospital East, Kashiwa, Chiba · The Cancer Institute Hospital of JFCR, Kōtō City · Aichi Cancer Center Hospital, Nagoya
Registry updated 2026-11-04
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
National Hospital Organization Nagoya Medical Center, Nagoya · The Cancer Institute Hospital of JFCR, Tokyo
Registry updated 2026-11-04
NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Trial Treatment · Phase 1 · Eli Lilly and Company
National Cancer Center Hospital East, Chiba · Kyoto University Hospital, Kyoto · The University of Osaka Hospital, Osaka
Registry updated 2026-11-04
NCT06095089
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
The Cancer Institute Hospital of JFCR, Tokyo
Registry updated 2026-11-03
NCT07164443
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Institute of Science Tokyo Hospital, Bunkyō City · Kyushu University Hospital, Fukuoka · Gifu University Hospital, Gifu · Saitama Medical University International Medical Center, Hidaka · Kanazawa University Hospital, Kanazawa · National Cancer Center Hospital East, Kashiwa · Kobe University Hospital, Kobe · National Hospital Organization Shikoku Cancer Center, Matsuyama · National Hospital Organization Tokyo Medical Center, Meguro-Ku · Toho University Sakura Medical Center, Sakura · Hokkaido University Hospital, Sapporo · Yokohama City University Medical Center, Yokohama · Yokohama City University Hospital, Yokohama · Yokosuka Kyosai Hospital, Yokosuka
Registry updated 2026-11-03
NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Juntendo University Hospital, Bunkyō City · Kansai Medical University Hospital, Hirakata · Kanazawa University Hospital, Kanazawa · Kobe University Hospital, Kobe · Kitasato University Hospital, Sagamihara · Shizuoka Cancer Center, Sunto-gun · Yokohama City University Medical Center, Yokohama
Registry updated 2026-11-03
NCT07832292
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
Kobe University Hospital, Kobe
Registry updated 2026-11-03
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Trial Treatment · Phase 3 · Pfizer
Chiba Cancer Center, Chiba · National Hospital Organization Kyushu Cancer Center, Fukuoka · Kanazawa University Hospital, Kanazawa · National Cancer Center Hospital East, Kashiwa · Kobe University Hospital, Kobe · National Hospital Organization Kumamoto Medical Center, Kumamoto · National Hospital Organization Shikoku Cancer Center, Matsuyama · Osaka International Cancer Institute, Osaka · National Hospital Organization Hokkaido Cancer Center, Sapporo · Hokkaido University Hospital, Sapporo · Keio University Hospital, Shinjuku-ku · The University of Osaka Hospital, Suita · Yamagata University Hospital, Yamagata · Yokohama City University Medical Center, Yokohama · Yokosuka Kyosai Hospital, Yokosuka
Registry updated 2026-10-30
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
University of Yamanashi Hospital ( Site 1506), Chūō · Kyushu University Hospital ( Site 1515), Fukuoka · Harasanshin Hospital ( Site 1517), Fukuoka · Gifu University Hospital ( Site 1527), Gifu · University of the Ryukyus Hospital ( Site 1519), Ginowan · Hamamatsu University Hospital ( Site 1520), Hamamatsu · Hiroshima University Hospital ( Site 1512), Hiroshima · Kagoshima City Hospital ( Site 1528), Kagoshima · Kagoshima University Hospital ( Site 1518), Kagoshima · Kanazawa Medical University Hospital ( Site 1507), Kahoku-gun · Shonan Kamakura General Hospital ( Site 1530), Kamakura · Hospital of the University of Occupational and Environmental Health, Japan ( Site 1510), Kitakyushu · Kobe University Hospital ( Site 1511), Kobe · Dokkyo Medical University Saitama Medical Center ( Site 1502), Koshigaya · National Hospital Organization Kumamoto Medical Center ( Site 1524), Kumamoto · Kurume University Hospital ( Site 1516), Kurume · University Hospital,Kyoto Prefectural University of Medicine ( Site 1525), Kyoto · The Jikei University Hospital ( Site 1504), Minato · Nagano Municipal Hospital ( Site 1526), Nagano · Nagasaki University Hospital ( Site 1523), Nagasaki · Nagoya University Hospital ( Site 1508), Nagoya · Niigata Cancer Center Hospital ( Site 1529), Niigata · Bell Land General Hospital ( Site 1509), Sakai · Toho University Sakura Medical Center ( Site 1503), Sakura · Sapporo Medical University Hospital ( Site 1501), Sapporo · Hokkaido University Hospital ( Site 1500), Sapporo · Tokyo Women's Medical University ( Site 1505), Shinjuku · Tokushima University Hospital ( Site 1513), Tokushima · Ehime University Hospital ( Site 1514), Tōon · Yamaguchi University Hospital ( Site 1522), Ube · Oita University Hospital ( Site 1521), Yufu
Registry updated 2026-10-30
NCT07288359
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Kyoto
Registry updated 2026-10-29
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Trial Treatment · Phase 1/2 · Pfizer
National Cancer Center Hospital East, Kashiwa
Registry updated 2026-10-28
NCT07332455
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Tokyo
Registry updated 2026-10-28
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Saitama Medical University International Medical Center, Hidaka · HAKUAIKAI Social Medical Corporation Sagara Hospital, Kagoshima · Kanagawa Cancer Center, Kanagawa · National Cancer Center Hospital East, Kashiwa-shi · NHO Shikoku Cancer Center, Matsuyama · Shizuoka Cancer Center, Nagaizumi-chō · Aichi Cancer Center Hospital, Nagoya · Kindai University Hospital, Osakasayama-Shi · Saitama Cancer Center, Saitama · National Cancer Center Hospital, Tokyo · Showa Medical University Hospital, Tokyo · Cancer Institute Hospital of JFCR, Tokyo · Yokohama City University Medical Center, Yokohama
Registry updated 2026-10-26
NCT07244341
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 1 · Daiichi Sankyo
National Cancer Center Hospital East, Kashiwa-shi · Kobe City Med Cen Gen Hosp., Kobe · Cancer Institute Hospital of JFCR, Kōtoku · Toho University Sakura Medical Center, Sakura-shi
Registry updated 2026-10-26
NCT07730021
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Trial Treatment · Phase 1/2 · Astellas Pharma Global Development, Inc.
National Cancer Center Hospital, Chuo Ku · The Cancer Institute Hospital of JFCR, Koto-ku
Registry updated 2026-10-26
NCT07570979
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
Trial Treatment · Phase 1 · Novartis Pharmaceuticals
Hirakata
Registry updated 2026-10-23
NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Trial Treatment · Phase 1/2 · AstraZeneca
Chūōku · Kashiwa · Kōtoku
Registry updated 2026-10-22
NCT04606446
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Pfizer
National Cancer Center Hospital, Chuo Ku · National Cancer Center Hospital East, Kashiwa · Aichi Cancer Center Hospital, Nagoya · Kanagawa Cancer Center, Yokohama
Registry updated 2026-10-21
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Chuo Ku · Fukuoka · Fukushima · Ishikawa · Kashiwa · Kobe · Kyoto · Sapporo · Yokohama
Registry updated 2026-10-21
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Akita University Hospital ( Site 0728), Akita · University of Fukui Hospital ( Site 0735), Eiheiji-cho,Yoshida-gun · Kyushu University Hospital ( Site 0745), Fukuoka · Fukushima Medical University Hospital ( Site 0758), Fukushima · Gifu University Hospital ( Site 0736), Gifu · Kansai Medical University Hospital ( Site 0739), Hirakata · Hiroshima University Hospital ( Site 0743), Hiroshima · Kagoshima University Hospital ( Site 0754), Kagoshima · Nara Medical University Hospital ( Site 0742), Kashihara · Kagawa University Hospital ( Site 0744), Kita · Hospital of the University of Occupational and Environmental Health, Japan ( Site 0746), Kitakyushu · Kobe University Hospital ( Site 0741), Kobe · National Hospital Organization Kumamoto Medical Center ( Site 0749), Kumamoto · The Jikei University Hospital ( Site 0731), Minato · Miyazaki Prefectural Miyazaki Hospital ( Site 0752), Miyazaki · University of Miyazaki Hospital ( Site 0751), Miyazaki · Kanazawa Medical University Hospital ( Site 0734), Mukai-awagasaki · Nagano Municipal Hospital ( Site 0757), Nagano · National Hospital Organization Oita Medical Center ( Site 0750), Ōita · National Hospital Organization Nagasaki Medical Center ( Site 0748), Ōmura · Saga-Ken Medical Centre Koseikan ( Site 0747), Saga · Bell Land General Hospital ( Site 0740), Sakai · Toho University Sakura Medical Center ( Site 0730), Sakura · Sapporo Medical University Hospital ( Site 0726), Sapporo · Hokkaido University Hospital ( Site 0756), Sapporo · Nanbu Tokushukai Hospital ( Site 0755), Shimajiri · The University of Osaka Hospital ( Site 0738), Suita · Nihon University Itabashi Hospital ( Site 0732), tabashi City · Mie University Hospital ( Site 0737), Tsu · Yokohama City University Medical Center ( Site 0733), Yokohama
Registry updated 2026-10-20
NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Trial Treatment · Phase 3 · Amgen
Nippon Medical School Hospital, Bunkyo-ku · Kyushu University Hospital, Fukuoka · Saitama Medical University International Medical Center, Hidaka-shi · Kanazawa University Hospital, Kanazawa · Kagawa University Hospital, Kita-gun · Kobe University Hospital, Kobe · Dokkyo Medical University Saitama Medical Center, Koshigaya-shi · The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku · National Hospital Organization Shikoku Cancer Center, Matsuyama · The Jikei University Hospital, Minato-ku · Nagoya University Hospital, Nagoya · Osaka International Cancer Institute, Osaka · Kitasato University Hospital, Sagamihara-shi · The University of Osaka Hospital, Suita-shi · Toyama University Hospital, Toyama
Registry updated 2026-10-20
NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Trial Treatment · Phase 3 · AstraZeneca
Chiba · Chūōku · Fukuoka · Hamamatsu · Kamakura-shi · Kanazawa · Kashiwa · Kobe · Kyoto · Sapporo · Suita-shi · Yokohama
Registry updated 2026-10-19

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error